Commentary

The debate over “clean” coal technology to address future energy needs continues with a Wisconsin twist, according to columnist Tom Still. In this edition of Inside Wisconsin, Still handicaps the chances of a proposed coal plant in Cassville, which could mix large amounts of locally...

One of the most contentious issues with early-stage companies is who, when it comes time to carve out employee equity incentives, gets diluted by the employee incentive pool? WTN guest columnist Paul Jones says the answer usually is the entrepreneur, who typically suffers all of...

WTN guest columnist Paul Jones describes himself as a recovering lawyer, but he not in denial about what kind of an attorney entrepreneurs want and need. In this column, Jones shares his thoughts about choosing top-notch counsel and offers the following advice: if necessary, don't...

Comparing courtroom drama to the process of wooing investors, attorney and columnist Sverre Roang says early-stage companies have their own discovery process to engage. In this WTN guest column, Roang notes that investors will conduct their own discovery, also known as due diligence, so entrepreneurs...

Many wonder how many more financial dominos would fall if the U.S. government takes no action to address Wall Street's financial crisis, but what about other sectors? Yer Biotech Blues columnist Michael Rosen wonders aloud whether a similar meltdown could be in the offing for...

Following the recent appeal of the Patent and Trademark Office's ruling on stem cell patents held by the Wisconsin Alumni Research Foundation, Wisconsin attorney Grady Frenchick is predicting that WARF will prevail. On the eve of the World Stem Cell Summit in Madison, Frenchick also...